2	huntington 's disease normal pressure hydrocephalus central nervous system cns tumor progressive supranuclear palsy subdural hematoma etc seizure disorder except case where the first seizure be within 10 year of the ad diagnosis and the patient be not prescribe anticonvulsant significant systemic medical|anticonvulsant[566,580]||||||||||926|926|anticonvulsant
3	illness use of medication likely to affect cns function e.g. benzodiazepine narcotic severe renal dysfunction with creatine clearance 30 ml/min which would affect serum lev level participation in another ad clinical trial within 3 month of screening or any ad clinical trial such a a vaccine that have|lev[779,782]|||30ml[744,749]||||3 month[839,846]||C3220305|1166072|5032|guaifenesin
3	illness use of medication likely to affect cns function e.g. benzodiazepine narcotic severe renal dysfunction with creatine clearance 30 ml/min which would affect serum lev level participation in another ad clinical trial within 3 month of screening or any ad clinical trial such a a vaccine that have|benzodiazepine[671,685]||||||||||1402|1402|benzodiazepine
3	illness use of medication likely to affect cns function e.g. benzodiazepine narcotic severe renal dysfunction with creatine clearance 30 ml/min which would affect serum lev level participation in another ad clinical trial within 3 month of screening or any ad clinical trial such a a vaccine that have|vaccine[894,901]||||||||||11094|11094|vaccine
4	potential long-term effect treatment with another study drug or investigational drug within 30 day of screening pregnant or lactate any other medical condition which be determine by the investigator to potentially create an undue risk for an adverse effect biomarker evidence unsupportive of a diagnosis|lactate[1036,1043]|||||||30 day[1004,1010]||C0376261|114202|114202|lactate
